Cover Image
市場調查報告書

全外顯子定序的全球市場 - 產品(系統,按套件[資料庫製備,靶向序列捕獲]),服務(定序),技術(合成定序),應用領域(癌症,單一遺傳基因病)預測

Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018

出版商 MarketsandMarkets 商品編碼 311018
出版日期 內容資訊 英文 245 Pages
訂單完成後即時交付
價格
Back to Top
全外顯子定序的全球市場 - 產品(系統,按套件[資料庫製備,靶向序列捕獲]),服務(定序),技術(合成定序),應用領域(癌症,單一遺傳基因病)預測 Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018
出版日期: 2014年08月14日 內容資訊: 英文 245 Pages
簡介

全外顯子定序(WES)是為了策略性配列分析基因的編碼領域,即所謂外顯子所用的新一代技術,藉由分析將近85%遺傳性疾病的外顯子來識別、判定造成米勒費雪症候群、老年癡呆症等各種疾病的遺傳性變異體的這個技術已經在研究上廣為利用。

本報告以全外顯子定序的全球市場為焦點,以今後到2018年這段期間為對象,依產品、服務、技術、應用領域及地區別提供其轉變預測,再彙整市場發展的影響要素、競爭環境、有力企業等調查、分析資訊。

第1章 簡介

  • 調查目的
  • 報告的內容說明
  • 調查對象市場
  • 報告的對象用戶層
  • 調查方法
    • 二級資訊來源
    • 直接取材
      • 由一級資訊來源得來的資料重點
    • 市場規模估算方法
    • 市場預測
    • 市場資料檢驗與資料三角法評估
  • 前提

第2章 摘要整理

第3章 市場概要

  • 簡介
  • 市場動態
    • 推動要素
      • 全外顯子定序技術的低成本和迅速性是市場發展的原動力
      • 在新科學研究的應用領域擴大加速了市場成長
      • 由於新消費階層引進全外顯子定序技術造成市場飛躍性成長
      • 有力研究機關的全球規模合作是藥物研發的契機
      • 促進全外顯子定序市場成長的新加入企業
    • 阻礙因素
      • 需要熟練的專家
      • 對補助金的高度依賴拖累了成長
      • 以全外顯子定序為中心的倫理·法律問題
    • 機會
      • 加速全外顯子定序技術需求的客製化醫療
  • 市場佔有率分析
    • 全外顯子定序產品市場 - 各主要企業
    • 全外顯子定序服務市場 - 各主要企業

第4章 全外顯子定序市場 - 產品與服務別

  • 簡介
  • 系統
    • HiSeq系列
      • HiSeq2500和HiSeq1500
    • Miseq
    • Ion Torrent平台
      • ION PGM和Ion Proton
  • 套件
    • 簡介
    • DNA片斷化,末端修復,Ateringu,尺寸選擇套件
    • 資料庫製備套件
    • 靶向序列捕獲套件
  • 服務
    • 簡介
    • 定序服務市場
    • 資料分析(生物資訊學)服務
    • 其他服務

第5章 全外顯子定序的全球市場 - 各技術

  • 合成的定序(SBS)
    • 技術
    • 優勢點
    • 課題
    • 應用領域
    • 平台
  • 離子半導體定序
    • 技術
    • 優勢點
    • 課題
    • 應用領域
    • 平台
  • 其他技術
    • 雜交定序法(SBL)
    • 焦磷酸定序

第6章 全外顯子定序市場 - 應用各領域

  • 簡介
  • 診斷
    • 癌症診斷
    • 單一遺傳基因病(孟德爾性疾病)
    • 單一遺傳基因型糖尿病
    • 其他診斷用途
      • 一般的疾病·複合疾病
      • 運動性疾病
    • 藥物研發·藥物開發
    • 農業及動物研究
    • 其他的應用領域

第7章 按全外顯子定序的全球市場 - 終端用戶

  • 終端用戶
  • 醫院,診療設備
  • 醫藥品·生物科技企業
  • 其他終端用戶

第8章 全外顯子定序的全球市場 - 各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區

第9章 競爭環境

  • 簡介
  • 協定,合作、合作關係
  • 新產品銷售
  • 擴張
  • 產業收購
  • 其他

第10章 企業簡介(企業簡述,財務概要,產品與服務,主要策略,最新發展,SWOT分析等)

  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Beijing Genomics Institute (Bgi)
  • Macrogen, Inc.
  • Eurofins Genomics, Inc.
  • Agilent Technologies, Inc.
  • Ambry Genetics
  • Genewiz, Inc.
  • Knome, Inc.
  • Roche Nimblegen, Inc.
  • Sengenics
目錄
Product Code: BT 2646

The applications of whole exome sequencing (WES) technologies have witnessed growth in recent years, which can be primarily attributed to the availability of advanced systems as well as the low cost of conducting exome sequencing, as compared with that of whole genome sequencing. The technological advancement is evident from the number of improved versions of existing sequencers released in recent years. For instance, in January 2014, the leading player in the whole exome sequencing market, Illumina, Inc. (U.S.), launched its NextSeq 500 System, which combines high-throughput performance with an affordable desktop form factor. This system is expected to enable researchers to perform sequencing in less than a day.

The major factors driving the growth of this market include its low cost and high speed, increase in applications areas for exome sequencing technologies, global alliances amongst leading research institutes to boost drug discovery, and the entry of new players in the whole-exome sequencing market. However, the high cost of instruments, the need for skilled professionals and high reliability on grants are hindering the market's growth.

The services segment has the largest share of the global whole exome sequencing market, since it has a variety of applications in all areas, including diagnostics, drug discovery and development, personalized medicine, and agriculture and animal research. Diagnostics emerged as the largest whole exome sequencing application, primarily because of an increase in the usage of exome sequencing technologies in cancer and rare disease research.

In the years to come, the whole exome sequencing market is expected to experience high growth in Asia, particularly in China and India. These countries will serve as new revenue pockets for whole exome sequencing products and services companies. High growth in these regions can be attributed to growth in the pharmaceutical and biotech industry and crop research, increased funding scenarios and collaborations with established market players. U.S. and Europe are witnessing steady growth owing to new applications in diagnostics, applied markets, and technological advancements in these regions. Rest of the world (RoW) includes regions such as Latin America, Africa, the Middle East, and Pacific countries, which have increased focus on research and gaining funds, thus increasing the potential for whole exome sequencing in these regions.

While the global whole exome sequencing products market witnesses low competitive intensity, competition is strong in the services market, with few big firms and many small companies in the fray offering similar services. These companies adopt various strategies (innovations, acquisitions, and geographic expansions) to increase their market shares and establish a strong foothold in the global market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of and services offered by top players in the whole exome sequencing market. The report analyzes the whole exome sequencing market by products and services
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the whole exome sequencing market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes markets for various whole exome sequencing technologies and services across geographies
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the whole exome sequencing market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products and services, distribution networks, and manufacturing capabilities of leading players in the whole exome sequencing market

Table of Contents

1. Introduction

  • 1.1. Objectives of the Study
  • 1.2. Report Description
  • 1.3. Markets Covered
  • 1.4. Stakeholders
  • 1.5. Research Methodology
    • 1.5.1. Secondary Research
    • 1.5.2. Primary Research
      • 1.5.2.1. Key Data Points From Primary Sources
    • 1.5.3. Market Size Estimation Methodology
    • 1.5.4. Market Forecast
    • 1.5.5. Market Data Validation and Data Triangulation
  • 1.6. Assumptions

2. Executive Summary

3. Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
      • 3.2.1.1. the Low Cost and High Speed of the Wes Technology to Drive the Growth of the Market
      • 3.2.1.2. Increasing Number of New Scientific Applications to Fuel the Market Growth
      • 3.2.1.3. Adoption of Wes Technology By New Consumers to Propel the Market Growth
      • 3.2.1.4. Global Alliances Amongst Leading Research Institutes to Trigger Drug Discovery
      • 3.2.1.5. Entry of New Players Is Propelling the Growth of the Wes Market
    • 3.2.2. Restraints
      • 3.2.2.1. Need for Skilled Professionals
      • 3.2.2.2. High Reliability on Grants to Restrict Growth
      • 3.2.2.3. Ethical and Legal Issues Related to Whole Exome Sequencing
    • 3.2.3. Opportunities
      • 3.2.3.1. Personalized Medicine to Fuel the Demand for Wes Technology
  • 3.3. Market Share Analysis
    • 3.3.1. Whole Exome Sequencing Products Market, By Key Player
    • 3.3.2. WES Services Market, By Key Player

4. Whole Exome Sequencing Market, By Products and Services

  • 4.1. Introduction
  • 4.2. Systems
    • 4.2.1. Hiseq Series
      • 4.2.1.1. Hiseq 2500 and Hiseq 1500
    • 4.2.2. Miseq
    • 4.2.3. ION torrent Platforms
      • 4.2.3.1. ION PGM and ION Proton
  • 4.3. Kits
    • 4.3.1. Introduction
    • 4.3.2. DNA Fragmentation, End Repair, A-Tailing, and Size Selection Kits
    • 4.3.3. Library Preparation Kits
    • 4.3.4. Target Enrichment Kits
  • 4.4. Services
    • 4.4.1. Introduction
    • 4.4.2. Sequencing Services Market
    • 4.4.3. Data Analysis (Bioinformatics) Services
    • 4.4.4. Other Services

5. Global Whole Exome Sequencing Market, By Technology

  • 5.1. Introduction
  • 5.2. Sequencing By Synthesis (SBS)
    • 5.2.1. Technology
    • 5.2.2. Advantages
    • 5.2.3. Challenges
    • 5.2.4. Applications
    • 5.2.5. Platforms
  • 5.3. ION Semiconductor Sequencing
    • 5.3.1. Technology
    • 5.3.2. Advantages
    • 5.3.3. Limitations
    • 5.3.4. Applications
    • 5.3.5. Platforms
  • 5.4. Other Technologies
    • 5.4.1. Sequencing By Ligation (SBL)
      • 5.4.1.1. Technology
      • 5.4.1.2. Advantages
      • 5.4.1.3. Limitations
      • 5.4.1.4. Applications
    • 5.4.2. Pyrosequencing
      • 5.4.2.1. Technology
      • 5.4.2.2. Advantages
      • 5.4.2.3. Applications

6. Whole Exome Sequencing Market, By Application

  • 6.1. Introduction
  • 6.2. Diagnostics
    • 6.2.1. Cancer Diagnostics
    • 6.2.2. Monogenic (Mendelian) Disorders
    • 6.2.3. Monogenic Types of Diabetes
    • 6.2.4. Other Diagnostic Applications
      • 6.2.4.1. Common Diseases and Complex Disorders
      • 6.2.4.2. Movement Disorders
      • 6.2.4.3. Hiv
  • 6.3. Drug Discovery and Development
  • 6.4. Personalized Medicine
  • 6.5. Agriculture & Animal Research
  • 6.6. Other Applications

7. Global Wholeexome Sequencing Market, By End User

  • 7.1. End Users
  • 7.2. Introduction
    • 7.2.1. Research Centers and Academic & Government Institutes
    • 7.2.2. Hospitals and Clinics
    • 7.2.3. Pharmaceutical & Biotechnology Companies
    • 7.2.4. Other End Users

8. Global Whole Exome Sequencing Market, By Geography

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. Increasing Use of Whole Exome Sequencing for Diagnosis of Rare Diseases Propels the Market Growth
    • 8.2.2. Government Funds for Exome Sequencing to Boost the Market
    • 8.2.3. Favorable Initiatives By the Canadian Government to Trigger Wes Market in the Country
    • 8.2.4. Conferences & Annual Meetings to Create Awareness About Wes Technologies
  • 8.3. Europe
    • 8.3.1. Investment in Rare Disease Research Likely to Boost the Wes Market in Europe
    • 8.3.2. Belgium to Contribute Substantially to Market Growth in Europe
    • 8.3.3. Increasing Funding for Molecular Diagnostics in Europe Is Likely to Propel the Growth of the Wes Market
    • 8.3.4. Conferences & Meetings Hosted in Europe to Fuel the Market Growth
  • 8.4. Asia
    • 8.4.1. Asian Countries Are Increasingly Focusing on Research in Wes
    • 8.4.2. Strategic Expansions and Aquisitions By Key Players in China to Boost the Market
    • 8.4.3. Regular Funding From Indian Government, An Impetus to the Wes Market
    • 8.4.4. Large Number of Conferences and Symposia in Asia to Drive Market Growth
  • 8.5. Rest of the World (ROW)
    • 8.5.1. Bioinformatics and Biotechnology Research in Latin America to Propel the Growth of the Market
    • 8.5.2. Genomic & Proteomic Research in Australia to Drive the Growth of the Market
    • 8.5.3. Flourishing Biotechnology & Pharmaceutical Markets in Brazil to Bolster the Growth of the Market

9. Competitive Landscape

  • 9.1. Introduction
  • 9.2. Agreements, Partnerships, & Collaborations
  • 9.3. New Product Launches
  • 9.4. Expansions
  • 9.5. Acquisitions
  • 9.6. Others

10. Company Profiles

  • 10.1. Illumina, Inc.
    • 10.1.1. Company Snapshot
    • 10.1.2. Financial Overview
    • 10.1.3. Products and Services
    • 10.1.4. Key Strategies
    • 10.1.5. Recent Developments
    • 10.1.6. SWOT
    • 10.1.7. MNM View
  • 10.2. Thermo Fisher Scientific, Inc.
    • 10.2.1. Company Snapshot
    • 10.2.2. Financial Overview
    • 10.2.3. Product Portfolio
    • 10.2.4. Key Strategies
    • 10.2.5. Recent Developments
    • 10.2.6. SWOT
    • 10.2.7. MNM View
  • 10.3. Beijing Genomics Institute (Bgi)
    • 10.3.1. Company Snapshot
    • 10.3.2. Financial Overview
    • 10.3.3. Services
    • 10.3.4. Key Strategies
    • 10.3.5. Recent Developments
    • 10.3.6. SWOT
    • 10.3.7. MNM View
  • 10.4. Macrogen, Inc.
    • 10.4.1. Company Snapshot
    • 10.4.2. Financial Overview
    • 10.4.3. Services
    • 10.4.4. Key Strategy
    • 10.4.5. Recent Developments
    • 10.4.6. SWOT
    • 10.4.7. MNM View
  • 10.5. Eurofins Genomics, Inc.
    • 10.5.1. Company Snapshot
    • 10.5.2. Financial Overview
    • 10.5.3. Services
    • 10.5.4. Key Strategies
    • 10.5.5. Recent Developments
    • 10.5.6. SWOT
    • 10.5.7. MNM View
  • 10.6. Agilent Technologies, Inc.
    • 10.6.1. Company Snapshot
    • 10.6.2. Financial Overview
    • 10.6.3. Products and Services
    • 10.6.4. Key Strategies
    • 10.6.5. Recent Developments
  • 10.7. Ambry Genetics
    • 10.7.1. Company Snapshot
    • 10.7.2. Financial Overview
    • 10.7.3. Services
    • 10.7.4. Key Strategy
    • 10.7.5. Recent Developments
  • 10.8. Genewiz, Inc.
    • 10.8.1. Company Snapshot
    • 10.8.2. Financial Overview
    • 10.8.3. Services
    • 10.8.4. Key Strategy
    • 10.8.5. Recent Developments
  • 10.9. Knome, Inc.
    • 10.9.1. Company Snapshot
    • 10.9.2. Financial Overview
    • 10.9.3. Products and Services
    • 10.9.4. Key Strategies
    • 10.9.5. Recent Developments
  • 10.10. Roche Nimblegen, Inc.
    • 10.10.1. Company Snapshot
    • 10.10.2. Financial Overview
    • 10.10.3. Products and Services
    • 10.10.4. Key Strategy
    • 10.10.5. Recent Developments
  • 10.11. Sengenics
    • 10.11.1. Company Snapshot
    • 10.11.2. Financial Overview
    • 10.11.3. Services
    • 10.11.4. Key Strategy
    • 10.11.5. Recent Developments

List of Tables

  • Table 1: Price Comparison for Whole Genome and Whole Exome Sequencing
  • Table 2: Employee Split for the Year 2013, By Geography
  • Table 3: Global Whole Exome Sequencing Market, By Products and Services, 2011-2018 ($Million)
  • Table 4: Global WES Products Market, By Type, 2011-2018 ($Million)
  • Table 5: Global Whole Exome Sequencing Products Market, By Region, 2011-2018 ($Million)
  • Table 6: Technical Specifications of Sequencing Systems
  • Table 7: Global WES Systems Market, By Region, 2011-2018 ($Million)
  • Table 8: Table: Comparison Between Sequencing Kits
  • Table 9: Global Whole Exome Sequencing Kits Market, By Type, 2011-2018 ($Million)
  • Table 10: Global WES Kits Market, By Region, 2011-2018 ($Million)
  • Table 11: DNA Fragmentation, End Repair, A-Telling, and Size Selection Kits Market, By Region, 2011-2018 ($Million)
  • Table 12: Whole Exome Sequencing Market Size for Library Preparation Kits, By Region, 2011-2018 ($Million)
  • Table 13: Market Size for Target Enrichment Kits, By Region, 2011-2018 ($Million)
  • Table 14: Global Whole Exome Sequencing Services Market, By Type, 2011-2018 ($Million)
  • Table 15: Global WES Services Market, By Region, 2011-2018 ($Million)
  • Table 16: Market Size for Sequencing Services, By Geography, 2011-2018 ($Million)
  • Table 17: Market Size for Data Analysis Services, By Region, 2011-2018 ($Million)
  • Table 18: Other Services Market, By Region, 2011-2018 ($Million)
  • Table 19: Global Market Size, By Technology, 2011-2018 ($Million)
  • Table 20: Market Size for Sequencing By Synthesis Technology, By Region, 2011-2018 ($Million)
  • Table 21: Market Size for ION Semiconductor Sequencing Technology, By Region, 2011-2018 ($Million)
  • Table 22: Market Size for Other Sequencing Technologies, By Region, 2011-2018 ($Million)
  • Table 23: Global Whole Exome Sequencing Market Size, By Application, 2011-2018 ($Million)
  • Table 24: Market Size for Diagnostic Applications, By Type, 2011-2018 ($Million)
  • Table 25: Market Size for Diagnostic Applications, By Region, 2011-2018 ($Million)
  • Table 26: Market Size for Cancer Diagnostics, By Region, 2011-2018 ($Million)
  • Table 27: Market Size for Monogenic Disorder Diagnostics, By Region, 2011-2018 ($Million)
  • Table 28: Market Size for Monogenic Types of Diabetes, By Region, 2011-2018 ($Million)
  • Table 29: Market Size for Other Diagnostic Applications, By Region, 2011-2018 ($Million)
  • Table 30: Market Size for Drug Discovery and Development, By Region, 2011-2018 ($Million)
  • Table 31: Market Size for Personalized Medicine, By Region, 2011-2018 ($Million)
  • Table 32: Market Size for Agriculture and Animal Research, By Region, 2011-2018 ($Million)
  • Table 33: Market Size for Other Applications, By Region, 2011-2018 ($Million)
  • Table 34: Global Whole Exome Sequencing Market Size, By End User, 2011-2018 ($Million)
  • Table 35: Market Size for Research Centers and Academic & Government Institutes, By Region, 2011-2018 ($Million)
  • Table 36: Market Size for Hospitals and Clinics, By Region, 2011-2018 ($Million)
  • Table 37: Market Size for Pharmaceutical and Biotechnology Companies, By Region, 2011-2018 ($Million)
  • Table 38: Market Size forother End Users, By Region, 2011-2018 ($Million)
  • Table 39: Market Size, By Region, 2011-2018 ($Million)
  • Table 40: Conferences/Meetings/forums/Workshops in the U.S., 2014
  • Table 41: North America: Whole Exome Sequencing Market Size, By Technology, 2011-2018 ($Million)
  • Table 42: North America: Market Size, By Products and Services, 2011-2018 ($Million)
  • Table 43: North America: Whole Exome Sequencing Products Market Size, By Type, 2011-2018 ($Million)
  • Table 44: North America: WES Kits Market Size, By Type, 2011-2018 ($Million)
  • Table 45: North America: WES Services Market Size, By Type, 2011-2018 ($Million)
  • Table 46: North America: Market Size, By Application, 2011-2018 ($Million)
  • Table 47: North America: Market Size for Diagnostic Applications, By Type, 2011-2018 ($Million)
  • Table 48: North America: Market Size, By End User, 2011-2018 ($Million)
  • Table 49: Conferences/Meetings/Forums/Workshops in Europe, 2014
  • Table 50: Europe: Whole Exome Sequencing Market Size, By Technology, 2011-2018 ($Million)
  • Table 51: Europe: Market Size, By Products and Services, 2011-2018 ($Million)
  • Table 52: Europe: Whole Exome Sequencing Products Market Size, By Type, 2011-2018 ($Million)
  • Table 53: Europe: WES Kits Market Size, By Type, 2011-2018 ($Million)
  • Table 54: Europe: WES Services Market Size, By Type, 2011-2018 ($Million)
  • Table 55: Europe: Market Size, Application, 2011-2018 ($Million)
  • Table 56: Europe: Market Size for Diagnostic Applications, By Type, 2011-2018 ($Million)
  • Table 57: Europe: Market Size, By End User, 2011-2018 ($Million)
  • Table 58: Conferences/Meetings/Forums/Workshops in Asia, 2014
  • Table 59: Asia: Whole Exome Sequencing Market Size, By Technology, 2011-2018 ($Million)
  • Table 60: Asia: Market Size, By Products and Services, 2011-2018 ($Million)
  • Table 61: Asia: WES Products Market Size, By Type, 2011-2018 ($Million)
  • Table 62: Asia: WES Kits Market Size, By Type, 2011-2018 ($Million)
  • Table 63: Asia: WES Services Market Size, By Type, 2011-2018 ($Million)
  • Table 64: Asia: Market Size, Application, 2011-2018 ($Million)
  • Table 65: Asia: Market Size for Diagnostic Applications, By Type, 2011-2018 ($Million)
  • Table 66: Asia: Market Size, By End User, 2011-2018 ($Million)
  • Table 67: ROW: Whole Exome Sequencing Market Size, By Technology, 2011-2018 ($Million)
  • Table 68: ROW: Market Size, By Products and Services, 2011-2018 ($Million)
  • Table 69: ROW: Whole Exome Sequencing Products Market Size, By Type, 2011-2018 ($Million)
  • Table 70: ROW: Whole Exome Sequencing Kits Market Size, By Type, 2011-2018 ($Million)
  • Table 71: ROW: WES Services Market Size, By Type, 2011-2018 ($Million)
  • Table 72: ROW: Market Size, By Application, 2011-2018 ($Million)
  • Table 73: ROW: Market Size for Diagnostic Applications, By Type, 2011-2018 ($Million)
  • Table 74: ROW: Market Size, By End User, 2011-2018 ($Million)
  • Table 75: Agreement, Partnerships, & Collaborations, 2011-2014
  • Table 76: Key Players Focusing on New Product Launches, 2011-2014
  • Table 77: New Product Launches, 2011-2014
  • Table 78: Expansions, 2011-2013
  • Table 79: Acquisitions, 2011-2014
  • Table 80: Others, 2011-2014

List of Figures

  • Figure 1: Research Methodology
  • Figure 2: Sampling Frame: Primary Research
  • Figure 3: Market Size Estimation Methodology (1/3)
  • Figure 4: Market Size Estimation Methodology (2/3)
  • Figure 5: Market Size Estimation Methodology (3/3)
  • Figure 6: Market Sizing ($Value Analysis)
  • Figure 7: Market Share Assessment
  • Figure 8: Market Forecasting Model
  • Figure 9: Data Triangulation Methodology
  • Figure 10: Global Market Size, By Products and Services (2013-2018)
  • Figure 11: Global Market Size, By Geography, 2013 ($Million)
  • Figure 12: Market Dynamics
  • Figure 13: Whole Exome Sequencing Products Market Share, By Key Player
  • Figure 14: Whole Exome Sequencing Products Market Share, By Key Player
  • Figure 15: Market Segmentation
  • Figure 16: Commonly Available Sequencing Kits
  • Figure 17: DNA Fragmentation, End Repair, A-Tailing, and Size Selection Kits Workfolw
  • Figure 18: Wes Technology Market Segmentation
  • Figure 19: Market, By Application
  • Figure 20: Market, By End User
  • Figure 21: Geographic Split for Whole Exome Sequencing Market, By Products and Services, 2013 Vs. 2018 ($Million)
  • Figure 22: Global Market: Key Growth Strategies, 2011-2014
  • Figure 23: Key Players Focusing on Agreements, Partnerships, & Collaborations, 2011-2014
  • Figure 24: Key Players Focusing on Expansions, 2011-2014
  • Figure 25: Key Players Focusing on Acquisitions, 2011-2014
  • Figure 26: Key Players Focusing on Other Strategies, 2011-2014
Back to Top